{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:02:23Z","timestamp":1793790143054,"version":"4.6.1"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Bullous pemphigoid (BP) is the most common autoimmune-blistering disease, clinically characterized by erythematous urticarial plaques, blisters, and intense pruritus, induced by autoantibodies against two proteins of the dermo-epidermal junction, BP180 and BP230. A large number of autoimmune diseases are reported in the literature as BP comorbidities, such as multiple sclerosis, but only a few cases are in association with scleroderma and none in association with both.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We present the case of a 68-year-old woman affected by multiple sclerosis and scleroderma who developed severe bullous pemphigoid with a bullous pemphigoid disease area index of 60 and high titers of anti-BP180 and anti-BP230 autoantibodies by enzyme-linked immunosorbent assays. After 2 months of therapy with both intravenous and oral corticosteroids, the active lesions of bullous pemphigoid were remitted with no relapse.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Autoimmune diseases affecting the skin or organs where BP180 and BP230 are present could trigger an immune response to these antigens through an epitope-spreading phenomenon and, over the years, induce bullous pemphigoid onset.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1055045","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T11:47:01Z","timestamp":1670500021000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Francesco","family":"Moro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feliciana","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Didona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Pagnanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Zenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101432","article-title":"Bullous pemphigoid: trigger and predisposing factors.","volume":"10","author":"Moro","year":"2020","journal-title":"Biomolecules."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/jdv.13660","article-title":"Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis.","volume":"30","author":"Lai","year":"2016","journal-title":"J Eur Acad DermatolVenereol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.887279","article-title":"Case report: bullous pemphigoid associated with morphea and lichen sclerosus: coincidental diseases or pathogenetic association?","volume":"13","author":"Maglie","year":"2022","journal-title":"Front. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1684\/ejd.2017.3012","article-title":"Bullous pemphigoid and systemic sclerosis: an incidental association?","volume":"27","author":"Cozzani","year":"2017","journal-title":"Eur J Dermatol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/archderm.1981.01650110047018","article-title":"Coexistence of localized bullous pemphigoid, morphea, and subcorneal pustulosis.","volume":"117","author":"Bernstein","year":"1981","journal-title":"Arch Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000051588","article-title":"Bullous pemphigoid in a patient treated with UVA-1 phototherapyfor disseminated morphea.","volume":"202","author":"Sacher","year":"2001","journal-title":"Dermatology."},{"key":"B7","article-title":"Bullous pemphigoid in a patient with systemic sclerosis (scleroderma).","volume":"33","author":"Sherber","year":"2006","journal-title":"J Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: a population-based case-control study.","volume":"131","author":"Langan","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/srep37125","article-title":"Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish Care Register study.","volume":"6","author":"F\u00f6rsti","year":"2016","journal-title":"Sci Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1365-2133.2004.06338.x","article-title":"Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis?","volume":"152","author":"Laffitte","year":"2005","journal-title":"Br J Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.brainres.2007.04.073","article-title":"Distribution of collagen XVII in the human brain.","volume":"1158","author":"Sepp\u00e4nen","year":"2007","journal-title":"Brain Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/cne.20549","article-title":"Collagen XVII and BPAG1 expression in the retina: evidence for an anchoring complex in the central nervous system.","volume":"487","author":"Claudepierre","year":"2005","journal-title":"J Comp Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/1346-8138.13207","article-title":"Bullous pemphigoid: what\u2019s ahead?","volume":"43","author":"Furue","year":"2016","journal-title":"J Dermatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1055045\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T11:47:04Z","timestamp":1670500024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1055045\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":13,"alternative-id":["10.3389\/fmed.2022.1055045"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1055045","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]},"article-number":"1055045"}}